Bioequivalence of an orally disintegrating tablet compared to the oral tablet formulation of the antipsychotic aripiprazole

被引:0
|
作者
Boulton, D [1 ]
Dressler, D [1 ]
Kollia, G [1 ]
Vachharajani, M [1 ]
Mallikaarjun, S [1 ]
Carson, W [1 ]
Kornhauser, D [1 ]
机构
[1] Bristol Myers Squibb Co, Lawrenceville, NJ USA
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:476 / 476
页数:1
相关论文
共 50 条
  • [1] Bioequivalence of an orally disintegrating tablet compared to the oral tablet formulation of the antipsychotic aripiprazole
    Scott, K
    Boulton, D
    Dressler, D
    Kollia, G
    Vachharajani, N
    Mallikaarjun, S
    Carson, W
    Kornhauser, D
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S273 - S273
  • [2] FORMULATION DEVELOPMENT AND EVALUATION OF FAMCICLOVIR ORALLY DISINTEGRATING TABLET
    Patil, Dhananjay
    Sanaurrehman, Momin
    Bairagi, Vinod
    Abdurrahman
    Awais, Mohammed
    Karishma, Shrivastav
    More, Rajashri
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (09): : 8427 - 8439
  • [3] Pharmacokinetics and pharmacodynamics of an orally disintegrating tablet formulation of dexlansoprazole
    Kukulka, Michael
    Nudurupati, Sai
    Perez, Maria Claudia
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2016, 9 (06) : 759 - 769
  • [4] Formulation and Taste Masking of Ranitidine Orally Disintegrating Tablet
    Hesari, Zahra
    Shafiee, Akram
    Hooshfar, Shirin
    Mobarra, Naser
    Mortazavi, Seyed Alireza
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2016, 15 (04): : 677 - 686
  • [5] Bioequivalence of rimegepant, a small molecule CGRP receptor antagonist, administered as an oral tablet, a sublingual orally disintegrating tablet, and a supralingual orally disintegrating tablet: two phase 1 randomized studies in healthy adults
    Croop, Robert
    Bhardwaj, Rajinder
    Anderson, Matt S.
    Matschke, Kyle T.
    Hould, Jennifer
    Bertz, Richard
    Liu, Jing
    Lipton, Richard B.
    CEPHALALGIA, 2024, 44 (02)
  • [6] Design, Formulation, and Physicochemical Evaluation of Montelukast Orally Disintegrating Tablet
    Aslani, Abolfazl
    Beigi, Maryam
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2016, 7
  • [7] Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet
    Lines, C
    Visser, WH
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (03) : 322 - 322
  • [8] Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet
    Dowson, AJ
    Charlesworth, BR
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2003, 57 (07) : 573 - 576
  • [9] Bioequivalence assay between orally disintegrating and conventional tablet formulations in healthy volunteers
    Armando, Yara Popst
    Schramm, Simone Grigoleto
    Silva, Marina de Freitas
    Kano, Eunice Kazue
    Mori Koono, Eunice Emiko
    Porta, Valentina
    dos Reis Serra, Cristina Helena
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 366 (1-2) : 149 - 153
  • [10] Orally disintegrating metoclopramide tablet approved
    不详
    NURSE PRACTITIONER, 2009, 34 (12): : 56 - 56